NCT03301168: Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 120 planned
- Started
- Apr 2014
- Primary completion
- 11 May 2021
- Arms
- BPX-501 T cells and Rimiducid
- Results
- None posted
- 4 Oct 2017: Trial registered